Stephanie Lee, MD, MPH

Stephanie Lee, MD, MPH

Member, Associate Director
Clinical Research Division
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research
Fred Hutchinson Cancer Research Center


M.P.H, Harvard School of Public Health, 1996.
M.D., Stanford University of Medicine, 1990.
B.S., University of Washington, 1984.

Research Expertise:

Dr. Lee’s expertise and research interests focus on survivorship issues, quality-of-life and the impact of chronic graft-versus-host-disease.

Clinical Expertise:

Dr. Lee is a hematologist who provides hematopoietic cell transplants using bone marrow, peripheral blood and cord blood for patients with blood diseases such as leukemia and myelodysplastic syndrome.

Current Studies:

NIH/NCI: Immune mediated disorders after allogeneic hematopoietic cell transplantation, Principal Investigator, 9/25/09 – 8/31/14.

NIH/NCI: Improving outcomes assessment in chronic GVHD, Principal Investigator, 3/1/13 – 2/28/18.

NIH/NCI: Internet studies to enhance long term survivorship after hematologic malignancy (PI: Syrjala), Co-investigator, 9/9/11 – 7/31/16.

NIH/NCI: Leadership of core long term follow-up program (PI: Appelbaum), Co-Investigator, 9/25/12 – 6/30/17.

NCI/NHLBI: BMT CTN 0902, Phase 3 randomized trial testing whether exercise or stress management improves quality of life in transplant patients (PI: Appelbaum), National Co-Principal Investigator, 7/1/12 – 6/30/17.

Phase 2 trial of low-dose interleukin-2 for steroid refractory chronic GVHD (PI: Koreth), Site Principal Investigator, 4/1/13 – 3/31/15.

Related News

Stephanie Lee, MD, PhD

Contact Information

(206) 667-6190
(206) 667-1034
Additional contact

Mail Stop: G6-100